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2ABSTRACT
Gold nanoparticles (GNPs) are intended for use within a variety of biomedical applications due 
to their physicochemical properties. Although, in general, biocompatibility of GNPs with 
immune cells such as macrophages and dendritic cells is well established, the impact of GNPs 
on B lymphocyte immune function remains to be determined. Since B lymphocytes play an 
important role in health and disease, the suitability of GNPs as a B cell-targeting tool is of high 
relevance. Thus, we provide information on the interactions of GNPs with B lymphocytes. 
Herein, we exposed freshly isolated human B lymphocytes to a set of well-characterized and 
biomedically relevant GNPs with distinct surface (polyethylene glycol (PEG), PEG/polyvinyl 
alcohol (PEG/PVA)) and shape (spheres, rods) characteristics. Polymer-coated GNPs poorly 
interacted with B lymphocytes, in contrast to uncoated GNPs. Importantly, none of the GNPs 
significantly affected cell viability, even at the highest concentration of 20 µg/ml over a 24 h 
suspension exposure period. Furthermore, none of the nanosphere formulations affected the 
expression of activation markers (CD69, CD86, MHC II) of the naïve B lymphocytes, nor did 
they cause an increase in the secretion of pro-inflammatory cytokines (i.e., IL-6, IL-1β). 
However, the absence of polymer coating on the sphere GNPs and the rod shape caused a 
decrease in IL-6 cytokine production by activated B lymphocytes, suggesting a functional 
impairment. With these findings, the present study contributes imperative knowledge towards 
the safe-by-design approaches being conducted to benefit the development of nanomaterials, 
specifically those as theranostic tools.  
KEYWORDS: gold nanoparticles, B lymphocytes, nanotoxicology, innate immunity, antigen 
presenting cells
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3B lymphocytes, often referred to as B cells, are an important sub-population of immune cells 
that are found throughout the body in the blood and lymphoid organs. As the sole producers of 
antibodies, they are essential effectors of protective immunity against infections. B cells also 
regulate the function of other immune cells, such as T lymphocytes, by presenting processed 
antigens via the major histocompatibility complex (MHC) and by secreting various cytokines 
that act as immune mediators. In pathological conditions, B cell dysfunction can lead to diseases 
such as allergy, autoimmunity or cancer.1  Because of their critical role in health and disease, B 
cells have generated increased interest in recent years as a target for drug delivery. Indeed, B 
cells have been successfully targeted by 80 nm lipid nanoparticles (NPs) carrying vaccines 
against influenza, HIV or Zika virus, or immunotherapies against allergic diseases.2–4 Despite 
these recent advances, the direct impact of NPs on B lymphocytes is still poorly understood. 
Importantly, B cells can respond in an innate, antigen-independent manner to different stimuli 
following activation via conserved pattern-recognition receptors, i.e. Toll-like receptors. This 
initial innate stimulation critically modulates subsequent activation and differentiation of B 
cells.5 Thus, in consideration of the human health impact of exposure to NPs it is imperative to 
understand how NPs may affect B cells, including their possible cytotoxic profile, as well as 
their ability to modulate their innate immune function.
The immunotoxicity of NPs has, to date, been studied essentially upon myeloid immune cells 
such as macrophages and dendritic cells. The phagocytotic nature of these cells leads to 
engulfment of the NPs, which in turn can promote interference with immune functions.6 Thus, 
some types of NPs (e.g., carbon nanotubes, zinc oxide and silica NPs) can cause dysfunctions 
in cell-intrinsic mechanisms such as autophagy and increases in secretion of pro-inflammatory 
cytokines, which consequentially may trigger oxidative stress and potentially genotoxicity.7–9 
To minimize the potential toxicity of NPs and to improve their half-life in the body, NP surface 
functionalization integrated with protective polymer surface coatings are used. Polyethylene 
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4glycol (PEG) and polyvinyl alcohol (PVA) as well as their co-polymer formulation are 
commonly used as protectors in cosmetic products, food supplements and pharmaceuticals.10,11 
However, use of these polymer coatings for NPs designed for therapeutic applications also has 
undesired effects: it may lead to the production of anti-polymer antibodies, which cause NP 
opsonization. This then increases clearance of the NPs and therefore affects the efficacy of 
treatment.12  To better evaluate the safety of the NPs for the immune system as a whole 
therefore, it is important to understand distinct effects that NPs may have on different immune 
subsets. Moreover, direct impact of NPs on B lymphocytes is currently a significant knowledge 
gap in the field, evidenced by the limited literature on the topic.  
Among the variety of nanomaterials available, gold core-based nanoparticles (GNPs) are 
frequently used as nanomedical tools in therapy, diagnostics and drug delivery. The optical 
properties of GNPs and their high biocompatibility make them highly useful imaging tools, 
biosensors, and nanocarriers.13 Furthermore, GNPs efficiently deliver vaccines and 
immunotherapies to immune cells, achieving effective immune responses with low amounts of 
cargo.14,15 In view of the emerging strategies to target B lymphocytes with nanocarriers, and 
the lack of information about NP immunotoxicity on B cells, we have investigated here the 
impact of a set of well-characterized GNPs on the phenotype and function of freshly isolated 
CD20+ human B lymphocytes from peripheral blood. 
RESULTS
GNPs with different polymer coatings and shapes were observed to be stable in a 
biological environment. To examine the impact of GNPs on B lymphocytes, we selected a 
panel of GNPs with different functionalizations and shapes that have previously been well 
characterized. Specifically, these were citrate-stabilized gold nanospheres (citrate-GNS) and 
polymer-functionalized gold nanospheres coated either with PEG (PEG-GNS) or a combination 
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5of PEG and PVA (PEG/PVA-GNS), as well as PEGylated gold nanorods (PEG-GNR).16,17 Gold 
core diameters were measured by transmission electron microscopy (TEM) as 13.4±2.3, 
15.7±1.9 and 14.6±1.8 nm for citrate-GNS, PEG-GNS and PEG/PVA-GNS, respectively. 
Dimensions of the PEG-GNR were measured at 57±12 nm x 15±3 nm, giving the aspect ratio 
of 3±0.8 (Figure. 1A and Table 1). 
UV-Vis measurements confirmed the stability in H2O of all GNPs, as previously described 
(Figure 1B).18 Since biological media can affect NP colloidal stability,19,20 GNPs were 
incubated for 24 h at 37° C, 5% CO2 in complete cell culture media supplemented with 10% 
human plasma (Roswell Park Memorial Institute 1640 medium + human plasma (RPMI+HP)) 
or in PBS. A loss in stability was observed for citrate-GNS due to aggregation in culture media, 
as previously described.21 Complete aggregation of citrate-GNS was present in PBS (Figure 
1B). In contrast, no signs of increased colloidal instability were detected for either type of 
polymer-coated GNS or the PEG-GNR. 
To further examine their colloidal stability, the hydrodynamic diameter of GNPs in biological 
media was characterized (Table 1). Negatively charged, non-polymer coated, citrate-stabilized 
NPs are known to interact strongly with a protein-rich environment, leading to a change in 
hydrodynamic diameter due to the formation of a protein corona.22–24 Indeed, dynamic 
depolarized light scattering (DDLS) results showed a strong increase in citrate-GNS diameter 
in RPMI+HP compared to H2O. For polymer-coated GNPs, the radius did not change in cell 
culture media, suggesting that a high-density PEG or PEG/PVA coating of the GNPs prevented 
surface protein absorption.25 In addition, PEG-GNR were tested for the efficiency of PEG 
coverage in relation to cetyltrimethylammonium bromide (CTAB) residues that might be still 
present from the synthesis. The results shown in Table 1 reveal that PEGylated GNRs presented 
higher hydrodynamic radii than the as-synthesized GNRs: 34.8±0.2 nm vs. 20.7±0.3 nm. The 
surface grafted PEG chains can acquire either a “brush” or “mushroom” conformation. The 
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6latter mainly occurs when the attachment distance of PEG to the surface  (D) is larger than the 
Flory radius (RF), while the brush conformation is observed when D is smaller than RF.26 
PEGylated GNRs presented a grafting coverage of 0.22 PEG molecules per nm2 and D of 2.26 
nm, as obtained by a method previously described.27 This indicated that the PEG layers 
deposited on the GNRs possessed a brush-like conformation because the RF for 5,000 Da PEG 
is 4.9 nm. This allowed us to conclude that no potential interference of otherwise toxic CTAB28 
remained on the surface of the GNRs.29
The significance of the NP surface charge and the role that it plays in the NP-cell interface is 
frequently stressed.30,31  We assessed the effect of the biological environment on the surface 
charge of GNPs and found that the charge of citrate-GNS considerably changed in RPMI+HP 
compared to H2O, most likely due to the surface adsorption of the plasma protein.32,33  In 
contrast, polymer-coated GNPs presented a slightly negative charge in both H2O and RPMI+HP 
with no major change (Table 1). This confirms that surface charge can vary significantly 
depending on the GNP surface chemistry, therefore, well-designed polymer functionalization 
is needed in order to avoid unwanted interactions of GNP with biological media. 
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7Figure 1. Characterization of gold nanoparticles (GNPs). (A) Representative TEM images of 
citrate-stabilized gold nanospheres (Citrate-GNS), gold nanospheres with a polyethylene glycol 
polymer coating (PEG-GNS), gold nanospheres with a combination of PEG and PVA polymer 
coating (PEG/PVA-GNS), and gold nanorods with PEG coating (PEG-GNR) in H2O. Scale 
bars: 100 nm. (B) UV-Vis spectra of GNPs in different biological media. Each spectrum was 
normalized relative to their maximum wavelength. RPMI+HP: complete culture medium 
consisting of Roswell Park Memorial Institute 1640 with 1% Penicillin/Streptomycin, 1% L-
Glutamine and 10% human plasma.
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8Table 1. Characterization of gold nanoparticle size and surface charge in complete culture 
medium, phosphate buffered saline (PBS) and water (H2O). 
Size (nm) ζ-potential (mV)
TEM (dc) DDLS (dh) H2O PBS RPMI+HP
H2O RPMI+HP
Citrate-GNS 13.4±2.3 16.8±0.1 48.0±0.5 -34.7±1.0 Aggregated -9.7±2.1
PEG-GNS 15.7±1.9 26.8±0.3 27.1±0.2 -5.8±1.3 - 6.8±0.8 -7.4±1.4
PEG/PVA-GNS 14.6±1.8 23.7±0.8 25.5±1.6 -6.5±0.9 -13.7±0.9 -8.9±1.6
PEG-GNR
Length: 57±12
Width: 15±3
34.8±0.2 33.9±0.3 -13.6±1.5 -3.4±1.7 -9.9±2.9
GNR n/a 20.7±0.3 n/a n/a n/a n/a
dc: core diameter, dh: hydrodynamic diameter, RPMI+HP: complete culture medium 
consisting of Roswell Park Memorial Institute 1640 with 1% Penicillin/Streptomycin, 1% L-
Glutamine and 10% human plasma.
GNPs do not affect B lymphocyte viability. The biological impact of GNPs on immune 
cells varies according to their physicochemical properties. Several groups have shown that 
characteristics such as size, shape and polymer coating affect the toxicity of GNPs on 
macrophages and dendritic cells.34–36 To assess whether the GNPs described above impact B 
lymphocyte viability, total CD20+ human B lymphocytes were freshly isolated from the blood 
of healthy donors and exposed to increasing concentrations of GNPs. This cell population 
consists mainly of naïve B cells (65-75%), with 20-25% memory B cells.37 A 24 h exposure 
time was selected in order to detect early B-cell responses toward GNPs. Then, cells were 
stained with amine-reactive fluorescent viability dye (Zombie NIR) and analyzed by flow 
cytometry. The polymer-functionalized GNS (PEG and PEG/PVA) as well as citrate-GNS 
caused no significant cell death at concentrations up to 20 µg/ml (Figure 2A). PEG-GNRs, 
studied at the highest concentration of 20 µg/ml only, also did not impact B cell viability. This 
latter finding demonstrating that neither the type of polymer coating nor geometry impacts upon 
B cell viability following GNP exposure (Figure 2B). In addition, phase contrast images did not 
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9show decrease in B cell density nor a change in cell morphology upon 24h GNP exposure 
(Figure S1A).
The small molecule R848 has been reported as an antigen-independent immune activator and 
stimulator of B lymphocyte proliferation by signaling via the receptor TLR7.38,39 Importantly, 
B cell viability was not compromised following exposure to GNPs together with the stimulant, 
irrespective of their shape or functionalization (Figure 2). 
Figure 2. GNPs do not impact upon B lymphocyte viability. Viability of human B lymphocytes 
was determined by staining cells with Zombie NIR viability dye (1:1000) and measured by flow 
cytometry after 24 h exposure to GNS (5-20 μg/ml) with different surface functionalizations 
(A) or to PEG-GNR (20 μg/ml) (B). Cells were incubated with and without the 
immunostimulant R848 (2 μg/ml). Data are presented relative to control cells without GNP 
exposure (=100%). Data represent mean ± SD of three separate experiments on different donors 
(n=3). Data were assessed by s two-way ANOVA, followed by Tukey’s multiple comparison 
post-hoc test. The alpha value was set at 0.05. 
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10
Citrate-GNPs are taken up by B lymphocytes, but not polymer-coated GNPs. B 
lymphocytes are professional antigen-presenting cells and as such they have the ability to take 
up pathogens, in particular via B cell receptor-mediated endocytosis.40 To examine whether B 
lymphocytes could take up GNP, freshly isolated human B cells were exposed to GNPs for 24 
h. The highest GNP concentration tested (20 μg/ml) was considered to be in the sub-lethal range 
as it did not cause significant B cell death. Therefore, it was further used in NP-cell association 
experiments. Macrophages and dendritic cells are professional phagocytotic cells and known to 
easily take up NPs.41 Therefore, human monocytes-derived macrophages (MDMs) and 
monocyte-derived dendritic cells (MDDCs) were also exposed to the previously described 
GNPs under the same conditions as the B cell experiments. MDMs and MDDCs served as a 
control for GNP-B cell interaction as well as for comparison of GNP-B cell association across 
different APC types. 
The cells and the GNP uptake were first visualized by dark field hyperspectral imaging (DF-
HSI) coupled with fluorescent detection. For citrate-GNS, which were noted to readily 
aggregate in biological media, clusters of NPs were clearly visible on the surface of B cells 
(Figure 3A). The particles were also detectable within the B cells themselves (insert Figure 3A). 
Citrate-GNS were further observed to be internalized by MDMs and MDDCs, as expected for 
these highly phagocytotic cell types (Figure 3A and Figure S1B and S1C). In contrast to citrate-
stabilized GNS, no interaction (either internalization or cell surface association) of polymer-
coated GNS with B lymphocytes was detected by DF-HSI. Similarly, PEG-GNR did not show 
any association with B cells (Figure S3). In MDMs, only a few intracellular aggregates of PEG-
GNS and PEG/PVA-GNS were detected by DF-HSI (Figure 3A). 
A subsequent approach to determine NP internalization by mammalian cells is through 
changes in light scattering detected by flow cytometry. This was previously reported by Zucker 
et al.,42 who demonstrated that the internalization of TiO2 NPs increased side scatter (SSC) and 
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11
decreased forward scatter (FSC) by epithelial cells. An increase in SSC was observed for B 
cells exposed to citrate-GNS, but not to polymer-coated GNS (Figure S4). In contrast, in MDMs 
and MDDCs, an increase in side scatter was observed for polymer-coated GNS. Overall, these 
results supported the observations collected from the DF-HSI images.
To quantify the uptake of GNPs with human B cells and to compare this to the association by 
other APCs, we measured the gold content within B cells and MDMs after exposure to 20 μg/ml 
of GNPs by using inductively coupled plasma mass spectroscopy (ICP-MS). This technique 
allows precise quantification of the gold ion content in biological samples.43 The uptake of 
citrate-GNS by B cells was confirmed, with approximately 10 µg gold measured per 106 cells 
(calculated by dividing measured GNP mass per total cell count and multiplying by 106) (Figure 
3B).  This corresponds to approximately 1% GNP-B cell association, as a function of measured 
GNP mass per total exposed GNP mass. In contrast, polymer-coated GNPs were detected at 
very low levels in B lymphocytes, confirming the findings obtained by DF-HSI. In comparison 
to B cells, MDMs internalized polymer-coated GNPs approximately 10 times more efficiently. 
Similar to B cells, citrate-GNS associated with MDMs with high efficiency compared to the 
polymer-coated GNS (Figure 3B). 
Here we demonstrate using DF-HSI that primary human B lymphocytes can internalize 
aggregated citrate-GNPs. This in accordance with a previous report in a mouse B cell line of 
the uptake of citrate GNPs aggregates, visualized in the endosomal compartments.44 Clearly, as 
shown in the present study, PEG-containing polymer coating prevents the uptake of the GNP 
both in B cells and in myeloid cells such as macrophages and dendritic cells. This agrees with 
previous results in dendritic cells, where GNPs coated with the combination of PEG/PVA had 
a significantly lower uptake than with PVA coating alone, presumably due to the shielding role 
of PEG.16 Our current results suggest that shape does not have a significant effect upon the 
uptake by either B cells or macrophages and dendritic cells. Nevertheless, the exact mechanisms 
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12
and possible surface receptors involved in the GNP uptake by B lymphocytes across different 
physiochemical properties of GNPs remain unknown.
Figure 3. Polymer-coated GNPs cause limited B lymphocyte uptake. (A) Dark field 
hyperspectral images of B cells and other antigen-presenting cells exposed to GNS at 20 µg/ml 
for 24 h. Scale bars: 5 µm. The white arrows indicate intracellular GNS. (B) Quantification by 
ICP-MS of gold ion content in B lymphocytes and MDMs exposed to GNPs at 20 µg/ml for 24 
h. Each dot represents one biological sample. Bars represent the mean ± SD of 3-4 biological 
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13
replicates; *p<0.05, **p<0.01. Data were evaluated by a one-way ANOVA, followed by 
Tukey’s multiple comparison post-hoc test.
GNPs do not impair B lymphocyte activation. Since gold-based nanoparticles have been 
shown in some instances to stimulate B cell lines,45 we investigated whether the GNPs used in 
this study could lead to antigen-independent activation of primary human B cells. The immune 
cell activation markers CD69, CD86 and MHC II were assessed on B cells by flow cytometry 
after exposure of the cells to GNPs. The TLR7 ligand R848 was used as positive control for 
antigen-independent B-cell activation.46 In the absence of R848, expression of activation 
markers was not increased after exposure to any of the tested GNS at concentrations up to 20 
µg/ml for 24 h (Figure 4A). Upon R848 stimulation, B cells showed upregulation of all three 
activation markers, as expected.  Importantly, exposure to GNS did not impair the 
pharmacological activation of B cells by R848. Similar results were obtained for PEG-GNRs 
at 20 µg/ml, which neither activated B cells nor inhibited their stimulation by R848 (Figure 
4B). The activation status of MDMs and MDDCs exposed to GNS was also assessed: the 
nanospheres did not activate these cells nor did they impair their stimulation by R848 (Figure 
S6). Thus, the GNPs used in this study did not stimulate human B cells, and they did not 
interfere with their drug-induced activation.
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14
Figure 4. B lymphocyte activation. Surface activation markers on B lymphocytes (CD69, CD86 
and MHC-II) measured by flow cytometry after 24 h exposure of B cells to GNS (5-20 μg/ml) 
with different surface functionalization (A) or to PEG-GNR (20 μg/ml) (B). B cells were 
incubated with or without the immunostimulant R848 (2 μg/ml). Each point represents one 
donor (n=3). Error bars: mean ± SD; *p<0.05. Data were evaluated by a two-way ANOVA, 
followed by Tukey’s multiple comparison post-hoc test. The alpha value was set at 0.05.
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15
Pro-inflammatory responses are not enhanced by GNPs. Nanoparticles have been shown 
to induce the production of pro-inflammatory mediators in immune cells.47 In particular, 
nanoparticles have been noted as able to trigger activation of the inflammasome complex, which 
leads to the secretion of pro-inflammatory cytokines such as IL1β.48  Since inflammation can 
result in severe side effects in patients, it is essential to test the pro-inflammatory potential of 
NPs destined for biomedical applications early in their development process. To assess whether 
GNPs induced the production of pro-inflammatory mediators in B cells, we measured the 
secretion of the pro-inflammatory cytokines IL-6 and IL-1β by B cells after a 24 h incubation 
with GNPs, with or without R848. The levels of cytokines were determined by ELISA in the 
cell culture supernatant. IL-6 and IL-1β secretion was not induced by GNS at concentrations 
up to 20 µg/ml, regardless of their functionalization, nor by PEG-GNR (Figure 5A). R848 
stimulation induced production of both IL-6 and IL1β by B cells, as expected for a TLR7 
agonist, but this cytokine production was not affected by polymer-coated GNS. Interestingly, 
PEG-GNR at 20 µg/ml caused a significant drop in IL-6 concentration from otherwise increased 
IL-6 levels of B cells induced by R848 (Figure 5B). Similarly, citrate-GNS caused suppression 
of IL-6 production in R848-activated cells in a concentration-dependent fashion, although the 
decrease was not statistically significant due to high variation between the cells from the 
different donors. 
In order to further compare the effect of GNPs across APCs, pro-inflammatory cytokines of 
MDMs and MDDCs were measured after exposure to all types of GNS at the highest 
concentration only (20 μg/ml). Similarly to B cells, none of GNS alone induced cytokine 
release. Interestingly, citrate-GNS did not interfere with efficiency of the cytokine release by 
MDMs and MDDCs, in contrast to the observations for activated B lymphocytes (Figure S7). 
The potential interference of GNPs, which possess light-absorbing properties, with optical-
based assays such as ELISA must be considered. To exclude such an interference, we carefully 
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assessed potential background caused by GNPs alone in the optical signal of the plate reader 
and found that all GNPs, even at the highest concentration of 20 µg/ml, were below the 
detection level of the ELISA (data not shown). Further, we controlled for the possible 
absorbance of cytokines onto the surface of the GNPs, which could impact upon the reliable 
reading of cytokine concentrations via this method. We detected no effect of the GNPs on 
cytokine concentrations in this cell-free assay (Figure S8). 
Figure 5. B lymphocyte pro-inflammatory response. Release of pro-inflammatory cytokines 
after 24 h exposure of B cells to GNS (5-20 μg/ml) with different surface functionalization (A) 
or to PEG-GNR (20 μg/ml) (B). B cells were incubated with or without the immunostimulant 
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R848 (2 μg/ml). Each point represents one donor (n=3). Error bars: mean ± SD; ***p<0.001. 
Data were evaluated by a two-way ANOVA, followed by Tukey’s multiple comparison post-
hoc test. The alpha value was set at 0.05.
DISCUSSION
The interactions of GNPs with B lymphocytes are important for biomedical applications, 
especially in view of the selective targeting of B lymphocytes by NPs. Although B lymphocytes 
are generally not considered professional phagocytic cells, they are capable of, in theory, 
actively taking up large particulate material through B-cell and complement receptors.49 Our 
results confirmed that GNPs which have a polymer-protected surface trigger very low uptake 
by primary human B lymphocytes. In contrast, uncoated GNPs, which were opsonized by 
plasma proteins, were highly taken up even by naïve B cells. This heightened interaction may 
be due, in part, to the formation of NP aggregates in the cell culture medium, which could 
trigger stronger internalization by the B cells compared to well-dispersed polymer-coated 
NPs.50 It has recently been shown that NP-bound antigens can be efficiently taken up by 
antigen-specific B lymphocytes, which then act as APCs to stimulate CD4 T cell responses.51  
Taken together, polymer-coated GNPs loaded with antigen may selectively target only those B 
lymphocytes recognizing their cognate antigen, thus enhancing selectivity of novel vaccine 
strategies. 
Cytotoxicity of GNPs, which depends on size, shape, dose, coating and surface 
characteristics, is a major concern. Our results show that the formulations of GNPs used in this 
study, including uncoated GNS and rod-shape GNPs, do not cause significant B cell 
cytotoxicity after 24 h exposure in vitro. These results give us valuable information for the 
further biomedical development of safe GNPs, particularly those that are foreseen to come in 
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direct contact with the immune system. In addition, gold nanomaterials have 
immunomodulatory properties and are able to induce activation in immune cells.52 One of the 
reasons is the insufficient GNP polymer surface coverage, which initiates binding and 
deformation of proteins that can then act as immunostimulants.53,54 Our data provide evidence 
that GNPs that are well-protected by polymers do not activate B lymphocytes, nor do they 
interfere with the action of an immunostimulatory drug (R848). 
Interestingly, we show that uncoated GNS, which aggregate in biological media, and rod-
shaped GNPs impaired IL-6 cytokine production in TLR7stimulated B lymphocytes. This 
suggests that the particle shape controls interference with early, antigen-independent activation 
events in B lymphocytes. However, further studies are needed to clarify possible mechanisms 
behind this impairment. 
CONCLUSION
The safety of NPs and their consequences on the immune system are of crucial importance. 
Indeed, as stressed by FDA draft guidelines on nanomaterials for the industry, characterization 
of the nanomaterial should be carefully assessed.55 The defined physicochemical characteristics 
of the NPs should be taken into consideration to cross-relate them for their stability in a 
biological environment and to determine the exact mechanisms of cell type-specific biological 
responses.70 Therefore, to evaluate the adequacy of GNP use in clinical studies, the impact of 
GNPs on the immune system (e.g., immunogenicity and immunotoxicity) is an important aspect 
that needs to be further investigated and specified. With our study, we have gained insight as to 
the impact of GNPs on B lymphocytes and showed that the absence of polymer coating and 
GNP shape are important factors that lead to different outcomes in GNP-B cell association and 
B cell efficiency of the cytokine release, which should be considered for future development of 
GNP for biomedical use. 
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METHODS
Chemicals and Reagents. All the chemicals were used without further purification. All 
chemicals and reagents purchased from Sigma-Aldrich (Switzerland) were used as received, 
unless otherwise stated. 
GNP synthesis. Methoxy-polyethylene glycol thiol (mPEG-SH; 5 kDa) was purchased from 
Creative PEGWorks. Polyvinyl alcohol (PVA, Mowiol 3-85, 14 kDa) was purchased from Omy 
AG. All glassware was cleaned with aqua regia and extensively rinsed with water prior to use. 
Milli-Q grade water was used in all preparations.
Citrate-stabilized gold nanoparticles (GNPs) 15 nm in diameter, were synthesized as 
previously described by Turkevich et al.56 Briefly, the aqueous solution of tetrachloroauric acid 
(HAuCl4 × 3H2O; 500 mL, 0.5 mM) was heated to 100 °C and left to boil for 10 min, which 
was followed by rapid addition of 25 mL of 34 mM sodium citrate previously heated to 60 °C. 
Within 20 min the color of the solution changed to red, indicating the formation of GNPs. After 
cooling down to the room temperature, NPs were kept in the glass container, in the dark, and at 
a temperature of 4 °C.
Preparation of PEG-GNS. Aqueous solution of mPEG-SH (3.4 mg/mL, 2.5 mL), equivalent 
to 10 PEG nm-2, were sonicated for 30 min and was subsequently mixed with 50 mL of citrate-
coated GNS suspension. The mixture was left to react at room temperature for 24 h. To remove 
any excess polymer, the PEGylated GNS were centrifuged at 10000 ×g for 1h and redispersed 
in water. 
Preparation of PEG/PVA-GNS. Separately, an aqueous solution containing 6 mg of polyvinyl 
alcohol (PVA) and 6 mg of mPEG-SH was prepared and sonicated for 20 min. Then, the 
polymer solution was added dropwise at room temperature under shaking to GNS suspension 
(20 mL). The mixture was left overnight under dark conditions. The final GNS-PEG/PVA 
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suspension was then centrifuged (10000 × g, 1h) to remove excess polymer and re-dispersed in 
water. 
Synthesis of GNRs. GNRs were prepared by the seed-mediated growth method.57 The Au 
seeds were synthesized by mixing a hexadecyltrimethylammonium bromide (CTAB) solution 
(0.1 M, 4.7 mL) with HAuCl4⋅3H2O (50 mM, 0.025 mL) at 28°C for 5 min. To this solution, 
fresh sodium borohydride (NaBH4) aqueous solution (10 mM, 0.3 mL) was added under 
vigorous stirring for 2 min. The mixture immediately turned light brown indicating the 
formation of seed particles. The seed dispersion was aged for 1 h at 28 °C before using it. 
Separately, a gold growth solution was prepared by adding HAuCl4⋅3H2O solution (50 mM, 
2.23 mL) to CTAB (0.1 M, 200 mL) and mixed by inversion. Silver nitrate (AgNO3) was then 
added (10 mM, 2.6 mL), followed by HCl (1 M, 3.84 mL) and mixed again by inversion. Next, 
L-ascorbic acid was added (0.1 M, 1.6mL) and the solution was mixed vigorously until the 
solution turned colorless. Finally, the Au seeds (960 µL) were added to the growth solution and 
followed by brief inversion mixing. The resulting suspension was left overnight at 28°C for the 
GNRs formation. GNRs then underwent further manipulation in order to have a polymer 
coating.
Preparation of PEG-GNR by two steps method. PEGylated GNRs were prepared as 
previously described by Kinnear et al.29 Briefly, the GNRs (10 mL, [Au] = 0.15 mM) were 
purified twice by centrifugation (8000 x g for 50 min) leading to a residual [CTAB] = 0.1 mM. 
Under shaking, a solution of mPEG-SH was added (10 mg/mL, 50.5 µL), equivalent to 10 PEG 
nm-2, and mixed over 24 hours. The partially PEGylated GNRs were then centrifuged at 8000 
× g for 50 min and redispersed in ethanol (90% v/v ethanol, 9.5 mL). To this, an ethanolic 
solution of mPEG-SH (1 mg/mL in 90% v/v ethanol, 505 µL) was added under shaking and 
gently mixed over 24 hours. Finally, completely PEGylated GNRs were centrifuged three times 
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at 8000 × g for 50 min to remove unreacted PEG and displaced CTAB with redispersion in 
water. 
GNP characterization. Transmission electron microscopy (TEM). GNP diameter was 
assessed through TEM, operating at 120 kV (FEI Technai Spirit microscope, USA) and 
equipped with Veleta CDD camera (Olympus, Japan). In order to avoid drying-related artifacts 
of drop-casting, Citrate-GNS and PEG-GNRs TEM samples were prepared as previously 
described.58 Briefly, samples were suspended to 1:1 ratio in the corresponding concentration of 
bovine serum albumin (BSA, Sigma-Aldrich, USA) solution and left at 4 °C overnight. 
Polymer-coated GNS samples were prepared without BSA incubation, in order to obtain more 
dense images of these type of NPs. A total of 5 µl of BSA-GNP (citrate-GNS, PEG-GNR) or 
GNP sample in H2O alone (PEG-GNS, PEG/PVA-GNS) was drop-casted on mash copper grids 
at a final GNP concentration 20 μg/mL and left to dry at room temperature. GNP size was 
subsequently calculated using ImageJ software at the following NP count: Citrate-GNS: n=132; 
PEG-GNS: n=103, PEG/PVA-GNS: n=149, PEG-GNR: n=220. Endotoxin levels of GNPs 
were determined by Pierce LAL Chromogenic Endotoxin Quantitation Kit (ThermoFisher, 
Switzerland), following the manufacturer’s guidelines (Figure S9). 
UV-Vis. UV-Vis spectra of GNPs was obtained using Jasco V-670 spectrophotometer. The 
colloidal stability was tested by incubation of GNPs in H20, 10mM PBS and culture medium 
(RPMI 1640 (Roswell Park Memorial Institute) with 10% human plasma, 1% PenStrep and 1% 
L-Glutamine) for 24 h at 37 °C, 5% CO2. All GNPs were diluted to concentration 0.01 mg/ml 
in each solution. 
Dynamic depolarized light scattering (DDLS). Citrate-GNS, PEG-GNS, PEG/PVA-GNS (all 
at 5 μg/mL) and PEG-GNR (20 μg/mL) were incubated in water or culture medium (RPMI with 
10% human plasma, 1 % PenStrep and 1% L-Glutamine), at 37 °C for 24 h. Then, dynamic 
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depolarized light scattering (DDLS) measurements were performed at constant temperature (21 
°C) at scattering angle of 30°, using a commercial goniometer instrument (3D LS Spectrometer, 
LS Instruments AG, Switzerland). To estimate the number-averaged hydrodynamic radii, the 
DDLS spectra were analyzed by the approach presented elsewhere.59
ζ-potential. GNP charge was acquired with phase amplitude light scattering analyzer (PALS) 
(Brookhaven ZetaPALS). GNPs were measured at 0.05 mg/ml, at RT in H2O (pH 7), PBS (pH 
7) and culture media (pH 7), where PBS and media were pre-diluted in H2O to 1:10. 
Measurements for each sample were obtained using the Smoluchowski model60 with 10 cycles 
of electrophoretic mobility (EPM) and 10 repetitions to gain mean and standard deviation data. 
All incubations of GNP in the cell-free biological media were solely performed for GNP 
characterization purposes.
Immune cell cultures. Human B lymphocytes. Buffy coats from healthy donors 
(BlutZentrum, Bern, Switzerland) were separated by gradient density (Lymphoprep™, 
Stemcell Technologies, Canada) followed by specific B lymphocyte magnetic bead isolation 
using anti-CD20 MicroBeads (Miltenyi Biotec, Germany). Fc receptor blocking reagent 
(Miltenyi Biotec) was added according to the manufacturer's instructions. A purity of > 96% 
CD20+ cells was obtained throughout the experiments (Figure S5). B lymphocytes were 
cultured in 6-well plates (0.25x106 cells/ml) at 37° C, 5% CO2 in RPMI 1640, supplemented 
with 10% autologous human plasma from each donor, 1% PenStrep (ThermoFisher Scientific, 
USA, #15140122) and 1% L-Glutamine (ThermoFisher, Scientific, USA, #25030081). The 
seeding concentration was chosen based on the median B lymphocyte number typically found 
in healthy human peripheral blood.61 
Monocyte sub-culture. Monocytes were isolated from buffy coats with anti-CD14 
MicroBeads (Miltenyi Biotec) and cultured in 6-well plates (106 cells/ml).62 Fc receptor 
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blocking reagent (Miltenyi Biotec) was added in the purification protocol. In order to 
differentiate monocytes to macrophages (monocyte-derived macrophages, MDM) or dendritic 
cells (monocyte-derived dendritic cells, MDDC), 10 ng/ml macrophage colony-stimulating 
factor (M-CSF) or 10 ng/ml granulocyte-macrophage colony-stimulating factor (GM-CSF) and 
10 ng/ml IL-4 were added into the culture, respectively, and incubated for 6 days at 37° C, 
5%CO2. All cell types were cultured at 37° C, 5% CO2 in RPMI 1640, supplemented with 10% 
autologous human plasma from each donor, 1% PenStrep (ThermoFisher Scientific, USA, 
#15140122) and 1% L-Glutamine (ThermoFisher, Scientific, USA, #25030081). 
Exposure to GNPs and stimulants. B lymphocytes. Cells were exposed to all GNS directly 
after purification for 24 h, at concentrations from 5-20 μg/ml and to PEG-GNRs at 20 μg/ml. 
MDMs/MDDCs. Cells were exposed to all GNS on day 6 of culture at 20 μg/ml for 24 h. 
R848 (Enzo, USA) at 2 µg/ml was used for B lymphocyte/MDMs/MDDMs and LPS control at 
100 ng/ml (Sigma-Aldrich, Switzerland) was used for MDM/MDDCs stimulation. The working 
concentrations of these immunostimulants was selected in order to induce robust activation in 
all donor samples.
GNP-cell association assessment. Light microscopy. Phase contrast images were captured 
at a magnification ×40, using an inverted light microscope (Motic AE2000, Germany) after 24 
h NP exposure (Figure S1).
Enhanced dark-field optical microscopy with high-resolution hyperspectral imaging. Cells 
exposed to GNPs were fixed with 4% paraformaldehyde (PFA), permeabilized with 0.01% 
TritonX-100 (Sigma-Aldrich, Switzerland) in PBS and stained with Rhodamine-Phalloidin, 
diluted 1:40 in PBS and 4′,6-diamidino-2-phenylindole (DAPI) using dilution 1:100 in PBS. 
Samples were imaged with high signal to noise ratio dark field hyperspectral imaging that uses 
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oblique angle lighting (CytoViva, Alburn, Alabama, US). The system is coupled with an 
Olympus BX-51 microscope outfitted with a fluorescence light source (X-Cite series 120), 
halogen light source (Dolan-Jenner DC-950), UPL Fluorite 100× objective, and SPECIM V10E 
imaging spectrograph with a PCO pixelfly detector (Kelhelm, Germany). All data acquisition 
was preformed using the same exposure time and magnification (100x oil immersion). Images 
from both dark field and fluorescent imaging were recorded using a 3D Exi blue camera 
(QImaging, Surry, Canada) and ENVI 4.8 software. Images obtained from both sources were 
overlaid using Image J software. Hyperspectral images were recorded using the same system 
and software but in spectral mode, using above mentioned detector. Due to the strong scattering 
of light, gold nanoparticles appear as the brightest signal on the image. Linear enhancement 
was used to obtain the best contrast of the object against the image background. This type of 
enhancement shows the full intensity range, from lowest to highest, without clipping.
ICP-MS. Chemicals: Acids (HNO3, HCl) were of PlasmaPure grade from SCP Science 
(Courtaboeuf, France). Ultrapure de-ionized water was provided by an Integral 3 Advantage 
A10 purification system (Merck-Millipore, Schaffhausen, Switzerland). The ICP-MS certified 
tuning solution consisted of 1 µg/L each of Li, Mg, Y, Ce, Tl and Co in a matrix of 2% HNO3 
was from SCP Science (cat n°701-021-194 5185-5959, batch n°S171122014). The gold 
certified standard solution (1000 ppm in 5% HCl) was purchased from Sigma-Aldrich (cat 
n°38168-100ML, batch n°BCBT4405).
 Sample preparation: B lymphocytes and MDMs were cultured and exposed to GNPs as 
described above. After 24 h, cells of 1-3 plates were pooled (cells in 18-54 ml), washed two 
times in 1x PBS (500 × g, 4 °C, 5 min) and counted (total cell number of the sample). After 
final centrifugation, supernatant was discarded and cell pellets were stored at -20 °C until 
further analysis. Cell pellets were re-suspended in 4.5 mL ultrapure Milli-Q water, with addition 
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of 0.5 mL of concentrated Aqua Regia (HNO3:HCl, 1:3), and digested by heating block for 1 
hour at 80°C (EasyDigest, Analab, France). Then, digested cell pellets were diluted in 10%(v/v) 
aqueous Aqua Regia (10% AR) to be within the calibration range of the ICP-MS method. Final 
quantification of GNP-cell association was calculated as ng/106 cells by dividing measured 
GNP mass per total cell number of each sample (cell count prior obtaining the cell pellet) and 
multiplication by 106.
Instrumentation: The Agilent 7700x ICP-MS system (Agilent Technologies, Basel, 
Switzerland) was equipped with a Micromist nebulizer and a Scott type spray chamber. The 
ICP-MS parameters were tuned with a certified solution to obtain the best sensitivity, resolution 
and the lower RSD on 7Li, 89Y and 205Tl, and also the lower oxide (156/140, CeO/Ce) and 
doubly charged (70/140, Ce2+/Ce) ratios. The ICP-MS parameters were optimized for the three 
collision cell modes (Table S1).  
ICP-MS method: Gold (197Au) was quantified (n=3) by ICP-MS with and without the use of 
a collision cell (CC), respectively termed [He] or [HEHe] and [No gas] mode. The two collision 
cell modes, [He] and [HEHe], with Helium gas at two flow rates: 4.3 mL/min and 10 mL/min, 
respectively, allow removing or reducing the potential spectral interferences. The ICP-MS 
calibration curve consisted of one blank (10% AR) and eight 197Au concentration levels (0.1, 
0.5, 1, 5, 10, 15, 20, 25 ppb in 10% AR). The linear regression correlation coefficients (R) were 
equal to 0.9997, 0.9995 and 0.9995 for 197Au measured in [No Gas], [He] and [HEHe] modes, 
respectively (Figure S2), which was in agreement with the FDA guidelines (R ≥ 0.998).63 
Evaluation of the ICP-MS method accuracy and precision was also evaluated. The results fulfill 
the precision (RSD ≤ 15%) and accuracy (100% ± 15%) criteria.43
Flow cytometry – Cell viability and immune cell status. Cells were stained for 15 min at 
room temperature with Zombie NIR™ Fixable Viability Kit (BioLegend, USA) and washed 
with FACS buffer (1% BSA, 0.5% sodium azide (Sigma-Aldrich, Switzerland) in PBS). Cells 
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were then stained for 30 min with the following antibodies at 1:100 (unless stated otherwise). 
B cells: anti-human CD20-FITC (B cell-specific marker, BD Biosciences, USA), anti-human 
CD69-Pacific Blue™ (BioLegend, USA), CD86-PE-Cy5 (BioLegend, USA) and HLA-DR-
PE-CF594 (at 1:300, BD Biosciences, USA); MDMs: CD14-FITC (monocyte/macrophage-
specific marker, BioLegend, USA), CD69-PacificBlue (BioLegend, USA), CD86-PE-Cy5 
(BioLegend, USA), HLA-DR-PE-CF594 (at 1:300, BD Biosciences, USA); MDDCs: CD1c-
PacificBlue (dendritic cell-specific marker, BioLegend, USA), CD80-FITC, CD86-PE-Cy5 
(BioLegend, USA), HLA-DR-PE-CF594 (at 1:300, BD Biosciences, USA).  Cells were then 
washed and re-suspended in 0.5 ml FACS buffer for flow cytometer analysis (BD LSR Fortessa, 
Switzerland). Three independent experiments were performed for each cell type and each 
sample was set up to capture up to 30,000 events. Gating strategies for all cell types are shown 
and explained in the supplementary information (Figure S5). All flow cytometry data were 
analyzed with FlowJo software (Version 10, Tree Star, USA). 
Pro-inflammatory response. After 24 h exposure of immune cells to GNPs, culture 
supernatants were collected and measured for concentrations of interleukin (IL)-6, IL-1β and 
tumor necrosis factor(TNF)-α by ELISA. The assay was performed according to the 
manufacturer’s instructions (Human IL-6 DuoSet ELISA, Human IL-1β/IL-1F2 DuoSet ELISA 
and Human TNF-α DuoSet ELISA, all from R&D, USA). The experiment for each analyte was 
conducted three times in duplicates (n=3).
To ensure that GNPs did not interfere with the spectrophotometric analysis, an interference 
test were performed for IL-6 ELISA kit: GNPs (20 μg/ml) alone were incubated in complete 
culture media for 24 h at 37 °C, 5% CO2.  Prior to the ELISA being conducted, GNP samples 
were incubated with a IL-6 standard (0-600 pg/ml) for 1 h at RT. Optical density for all the 
ELISA samples was measured at 450/570 nm, using a microplate reader (Benchmark 
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Microplate reader, BioRad, Cressier, Switzerland). The test experiments were performed once 
in triplicate (Figure S8).
Data and Statistical Analysis. Results are presented as a mean of three separate experiments 
(three different donors (n=3)) ± standard deviation (SD). Data were considered normally 
distributed and thus were evaluated using a non-parametric two-way analysis of variance 
(ANOVA) or one-way ANOVA. Subsequent analysis occurred in terms of a Tukey’s multiple 
comparison post-hoc test (GraphPad Prism 7 software, USA). Data was considered significant 
when *p<0.05, **p<0.01 and ***p<0.001. 
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